Neurofilament protein IVD, antibody

Neurofilament protein in-vitro diagnostics (IVDs) use antibodies to detect specific neurofilament proteins—such as light (NF-L), medium (NF-M), or heavy (NF-H)—in biological samples like blood or cerebrospinal fluid. Clinically, these tests help monitor neurodegenerative diseases, assess neuronal damage, or track disease progression by quantifying neurofilament levels, offering insights into conditions like Alzheimer’s, ALS, or traumatic brain injury.

These diagnostic tools are typically classified as in-vitro diagnostics and regulated under medical device frameworks, with compliance requirements varying by jurisdiction. They are commonly supplied as kits, reagents, or ready-to-use reagents for laboratory use, ensuring accurate detection and measurement of neurofilament biomarkers for clinical decision-making.